President Trump is scheduled to be in Philadelphia on Tuesday, September 15, 2020 at The National Constitution Center (NCC) in the Independence Mall area. Increased police presence is anticipated in Center City throughout Tuesday afternoon and evening. Please allow extra time if you are going to Wills Eye. Please be advised of area street closures to vehicles beginning at 1:00PM on Tuesday 9/15. Pedestrian access will also be limited in the area. This is subject to change and area restrictions, which could widen, will be lifted once the President departs the NCC. There are also demonstrations planned for Tuesday 9/15 around Independence Mall as well as City Avenue.

Jerry Shields, MD

Subspecialty: Ocular Oncology


Jerry A. Shields, MD is a world-renowned ophthalmologist and Director Emeritus of the Ocular Oncology Service at Wills Eye Hospital. He received his medical degree from University of Michigan Medical School and completed his residency at Wills Eye Hospital.

After residency, Dr. Shields trained as a retina fellow at Wills Eye followed by a fellowship in ophthalmic pathology at the Armed Forces Institute of Pathology. He went on to become one of the first pioneers in the use of radioactive plaques for the treatment of intraocular tumors.

Dr. Shields has trained more than 100 fellows from all parts of the world in ocular oncology. He has authored or co-authored more than 1,300 articles and 550 textbook chapters for a total of nearly 1,900 scientific publications. He has also authored or co-authored 13 textbooks and has given numerous talks and prestigious named lectures throughout the world.

Dr. Shields has won more than 40 awards. In 2012, the Asia Pacific Academy of Ophthalmology established the Jerry A. Shields, MD Lecture to be presented annually at their Congress. In March of 2013 Dr. Shields was awarded the National Physician of the Year Award for Clinical Excellence (top doctor in America) by Castle Connelly Medical, Ltd., New York, N.Y.

Dr. Shields has served on editorial boards in the United States, Great Britain, Germany and Denmark. He has been president of the Macula Society and was the first president of the International Society of Ocular Oncology.

View More


Wills Eye Hospital, Vitreoretinal Surgery – 1972, 1970; Armed Forces Institute of Pathology, Ophthalmic Pathology – 1971
Wills Eye Hospital – 1970
Medical School:
University of Michigan – 1964
Murray State University – 1960

Professor of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University

Honors and Awards

American Board of Ophthalmology – 1972

Language Spoken



Castle Connolly “National Physician of the Year” 2013 Philadelphia magazine “Top Doctors” 2011, 2012, 2013, 2014, 2015, 2016, 2017 Castle Connolly “America’s Top Doctors” 2011-2017

Areas of Interest:
Ocular Oncology Service in 1974. He has had long interest in eye cancer and has published over 800 articles on various subjects. His main interest is in the subject of choroidal melanoma and retinoblastoma. He pioneered new therapies and was instrumental in popularizing plaque raiotherapy for choroidal melanoma to save the patients eye. Along with the other members of the Ocular Oncology Service, he has continued to be a leader in eye cancer research nationally and internationally. He has published numerous textbooks and chapters on ocular tumors and is presently the President of the International Society of Ocular Oncology.

Jerry A. Shields, MD, Director of the Wills Eye Oncology Service, received the 2014 Laureate Award, the American Academy of Ophthalmology’s highest honor.

Wills Eye Hospital
840 Walnut Street, Suite 1440
Philadelphia, PA 19107 Google Maps